Cramer wants to use ‘every opportunity’ to buy more of this pharma stock

Jim and Jeff discuss earnings for this enterprise software company. They also talk about the latest moves for this biopharmaceutical stock. Finally, they break down the moves of this budget retailer.

Share

Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *